search
Back to results

Placebo and Active Controlled Study to Compare the Efficacy of Aspirin and Paracetamol in Treatment of Sore Throat Associated With a Common Cold

Primary Purpose

Common Cold, Pharyngitis, Tonsillitis

Status
Completed
Phase
Phase 4
Locations
United Kingdom
Study Type
Interventional
Intervention
Acetylsalicylic acid (Aspirin, BAYE4465)
Paracetamol
Placebo
Sponsored by
Bayer
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Common Cold focused on measuring Sore Throat

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Male and female patients
  • Onset of common cold within the past 5 days
  • Current sore throat
  • Confirmed presence of a tonsillo-pharyngitis

Exclusion Criteria:

  • Hypersensitivity to acetylsalicylic acid, salicylates, paracetamol, or any other NSAID
  • Pregnant or lactating women
  • History or acute state of peptic ulceration or gastrointestinal bleeding
  • History of bleeding tendency
  • History of asthma
  • Inability to breathe through the nose or a history of chronic mouth breathing
  • Other exclusion criteria may apply

Sites / Locations

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

Placebo Comparator

Arm Label

Arm 1

Arm 2

Arm 3

Arm Description

Outcomes

Primary Outcome Measures

Pain intensity difference to baseline of Acetylsalicylic Acid in comparison to Paracetamol

Secondary Outcome Measures

Pain intensity difference to baseline of Acetylsalicylic Acid in comparison to Placebo
Total pain relief of Acetylsalicylic Acid in comparison to Paracetamol
Total pain relief of Acetylsalicylic Acid in comparison to Placebo
Evaluation of Upper Respiratory Tract Infection symtoms
Adverse Event collection

Full Information

First Posted
May 17, 2011
Last Updated
December 10, 2014
Sponsor
Bayer
search

1. Study Identification

Unique Protocol Identification Number
NCT01465009
Brief Title
Placebo and Active Controlled Study to Compare the Efficacy of Aspirin and Paracetamol in Treatment of Sore Throat Associated With a Common Cold
Official Title
Double-blind, Randomized, Placebo-controlled, Single Dose, Parallel Group Study Evaluating Efficacy and Safety of 1000 mg Acetylsalicylic Acid and 1000 mg Paracetamol in Adult Patients With Sore Throat Associated With a Common Cold
Study Type
Interventional

2. Study Status

Record Verification Date
November 2011
Overall Recruitment Status
Completed
Study Start Date
November 2003 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
March 2005 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Bayer

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine the efficacy and safety of 1000 mg Aspirin (study medication) by comparing 1000 mg Paracetamol (study medication) in treating the symptoms of sore throat associated with a common cold. The study is designed to develop a treatment method against sore throat associated with a common cold which will have more advantages for patients than the methods that are currently available.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Common Cold, Pharyngitis, Tonsillitis
Keywords
Sore Throat

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
508 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Arm 1
Arm Type
Experimental
Arm Title
Arm 2
Arm Type
Active Comparator
Arm Title
Arm 3
Arm Type
Placebo Comparator
Intervention Type
Drug
Intervention Name(s)
Acetylsalicylic acid (Aspirin, BAYE4465)
Intervention Description
Single Administration of 2 tablets Acetylsalicylic acid (500 mg each); in addition, 2 tablets matching placebo to Paracetamol
Intervention Type
Drug
Intervention Name(s)
Paracetamol
Intervention Description
Single Administration of 2 tablets Paracetamol (500 mg each); in addition, 2 tablets matching placebo to Acetylsalicylic Acid
Intervention Type
Drug
Intervention Name(s)
Placebo
Intervention Description
Single Administration of 2 tablets matching Placebo to Acetylsalicylic Acid together with 2 tablets matching placebo to Paracetamol
Primary Outcome Measure Information:
Title
Pain intensity difference to baseline of Acetylsalicylic Acid in comparison to Paracetamol
Time Frame
For 6 hours after drug intake
Secondary Outcome Measure Information:
Title
Pain intensity difference to baseline of Acetylsalicylic Acid in comparison to Placebo
Time Frame
For 6 hours after drug intake
Title
Total pain relief of Acetylsalicylic Acid in comparison to Paracetamol
Time Frame
For 6 hours after drug intake
Title
Total pain relief of Acetylsalicylic Acid in comparison to Placebo
Time Frame
For 6 hours after drug intake
Title
Evaluation of Upper Respiratory Tract Infection symtoms
Time Frame
2 hours after drug intake
Title
Adverse Event collection
Time Frame
Up to 17 days after Screening

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Male and female patients Onset of common cold within the past 5 days Current sore throat Confirmed presence of a tonsillo-pharyngitis Exclusion Criteria: Hypersensitivity to acetylsalicylic acid, salicylates, paracetamol, or any other NSAID Pregnant or lactating women History or acute state of peptic ulceration or gastrointestinal bleeding History of bleeding tendency History of asthma Inability to breathe through the nose or a history of chronic mouth breathing Other exclusion criteria may apply
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Bayer Study Director
Organizational Affiliation
Bayer
Official's Role
Study Director
Facility Information:
City
Reading
State/Province
Berkshire
ZIP/Postal Code
RG2 7AG
Country
United Kingdom
City
Manchester
State/Province
Greater Manchester
ZIP/Postal Code
M15 6SX
Country
United Kingdom
City
Chorley
State/Province
Lancashire
ZIP/Postal Code
PR7 1NY
Country
United Kingdom
City
Wigan
State/Province
Lancashire
ZIP/Postal Code
WN6 9EW
Country
United Kingdom
City
Liverpool
State/Province
Merseyside
ZIP/Postal Code
L1 9AD
Country
United Kingdom
City
Liverpool
State/Province
Merseyside
ZIP/Postal Code
L22 0LG
Country
United Kingdom
City
Cardiff
State/Province
South Glamorgan
ZIP/Postal Code
CF1 3US
Country
United Kingdom
City
Birmingham
State/Province
West Midlands
ZIP/Postal Code
B15 2SQ
Country
United Kingdom

12. IPD Sharing Statement

Learn more about this trial

Placebo and Active Controlled Study to Compare the Efficacy of Aspirin and Paracetamol in Treatment of Sore Throat Associated With a Common Cold

We'll reach out to this number within 24 hrs